Eric Devroe
Directeur des opérations chez ACRIVON THERAPEUTICS, INC.
Fortune : 585 252 $ au 30/04/2024
Profil
Eric J.
Devroe was the founder of Opsonix, Inc. (founded in 2015) where he served as the Chief Executive Officer & Director from 2015 to 2018.
Dr. Devroe is also the founder of Xione Therapeutics, Inc...
Dr. Devroe's current job is as the Chief Operating Officer at Acrivon Therapeutics, Inc. since 2022.
Dr. Devroe's former jobs include working as a Scientist at Asuragen, Inc., as a Principal at Codon Devices, Inc., and as the VP-Business & Strategy Development at Metamark Genetics, Inc. Dr. Devroe's education includes a doctorate degree from Harvard University and an undergraduate degree from The University of Texas at Austin.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/05/2024 | 69 097 ( 0,22% ) | 585 252 $ | 30/04/2024 |
Postes actifs de Eric Devroe
| Sociétés | Poste | Début |
|---|---|---|
| ACRIVON THERAPEUTICS, INC. | Directeur des opérations | 01/08/2022 |
Anciens postes connus de Eric Devroe
| Sociétés | Poste | Fin |
|---|---|---|
Opsonix, Inc.
 Opsonix, Inc. Medical SpecialtiesHealth Technology Opsonix, Inc. manufactures and distributes medical devices. It commercializes and develops products to transform the treatment and diagnosis of sepsis. The company was founded on April 11, 2014 and is headquartered in Cambridge, MA. | Fondateur | 01/01/2018 |
Xione Therapeutics, Inc.
 Xione Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xione Therapeutics, Inc. engages in the provision of biotechnology services. The company is headquartered in Houston, TX. | Directeur Général | - |
Codon Devices, Inc.
 Codon Devices, Inc. Pharmaceuticals: MajorHealth Technology Codon Devices, Inc. produces pharmaceuticals and biorefineries for the production of industrial chemicals and bio-energy. The firm designs and constructs biological components such as enzymes, biopharmaceuticals, and cell lines for improved function. Its customers include the biotechnology, pharmaceutical, and agriculture sectors. The company was founded by Noubar B. Afeyan, George Church, Drew Endy, Joseph M. Jacobson and Jay Keasling in 2004 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Asuragen, Inc.
 Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | Corporate Officer/Principal | - |
Metamark Genetics, Inc.
 Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | Directeur des opérations | 23/03/2011 |
Formation de Eric Devroe
| Harvard University | Doctorate Degree |
| The University of Texas at Austin | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ACRIVON THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Asuragen, Inc.
Asuragen, Inc. Medical SpecialtiesHealth Technology Asuragen, Inc. develops molecular diagnostic products. Its products include AmplideX and QuantideX. It uses genomics to drive patient management through clinical testing solutions. The company was founded in March 2006 by Matthew M. Winkler and is headquartered in Austin, TX. | Health Technology |
Codon Devices, Inc.
Codon Devices, Inc. Pharmaceuticals: MajorHealth Technology Codon Devices, Inc. produces pharmaceuticals and biorefineries for the production of industrial chemicals and bio-energy. The firm designs and constructs biological components such as enzymes, biopharmaceuticals, and cell lines for improved function. Its customers include the biotechnology, pharmaceutical, and agriculture sectors. The company was founded by Noubar B. Afeyan, George Church, Drew Endy, Joseph M. Jacobson and Jay Keasling in 2004 and is headquartered in Cambridge, MA. | Health Technology |
Metamark Genetics, Inc.
Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | Health Services |
Opsonix, Inc.
Opsonix, Inc. Medical SpecialtiesHealth Technology Opsonix, Inc. manufactures and distributes medical devices. It commercializes and develops products to transform the treatment and diagnosis of sepsis. The company was founded on April 11, 2014 and is headquartered in Cambridge, MA. | Health Technology |
Xione Therapeutics, Inc.
Xione Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xione Therapeutics, Inc. engages in the provision of biotechnology services. The company is headquartered in Houston, TX. | Health Technology |